Signature Diagnostics Appoints Rainer Kramer to Chief Business Officer and Member of the Management Board
Dr. Kramer holds a Diploma in Molecular Biology and a Ph.D from the Max-Planck-Institute for Neurobiology. Throughout his career in corporate business development, he contributed or delivered numerous strategic partnerships and license deals encompassing technology platform and product deals as well as equity transactions with an aggregate value of several hundred million Euros. As a member of Jerini's M&A committee, he was instrumental in the sale of Jerini to Shire in 2008 and was Shire's appointed principal for the sale of JPT GmbH in 2009.
Most read news
Other news from the department people
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.